Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogenic Bone Marrow Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT04361058
What this trial is testing

Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic SyndromesMyelodysplastic Syndrome Acute Myeloid Leukemia
SCRI Development Innovations, LLC
Testing effectiveness (Phase 2)Study completedNCT02661035
What this trial is testing

Allo HSCT Using RIC for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+15 more
Masonic Cancer Center, University of Minnesota 156
Testing effectiveness (Phase 2)Study completedNCT01810588
What this trial is testing

Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation

Who this might be right for
Hematologic Malignancies
Weill Medical College of Cornell University 270
Early research (Phase 1)WithdrawnNCT00866346
What this trial is testing

PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation

Who this might be right for
Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01093586
What this trial is testing

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+73 more
Case Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Looking for participantsNCT01174108
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

Who this might be right for
Severe Aplastic AnemiaMDS (Myelodysplastic Syndrome)
National Heart, Lung, and Blood Institute (NHLBI) 120
Testing effectiveness (Phase 2)Study completedNCT01244906
What this trial is testing

Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

Who this might be right for
Hematologic Neoplasms
Northside Hospital, Inc. 26
Early research (Phase 1)Ended earlyNCT00003060
What this trial is testing

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Louisiana State University Health Sciences Center Shreveport 6
Large-scale testing (Phase 3)Study completedNCT00186823
What this trial is testing

Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
Leukemia, Acute Lymphocytic (ALL)Leukemia, Myeloid, Acute(AML)Leukemia, Myeloid, Chronic(CML)+4 more
St. Jude Children's Research Hospital 57
Large-scale testing (Phase 3)Study completedNCT00887068
What this trial is testing

Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)

Who this might be right for
LeukemiaAMLMDS
M.D. Anderson Cancer Center 187
Testing effectiveness (Phase 2)Study completedNCT03931291
What this trial is testing

APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia or Myelodysplastic Syndromes
Aprea Therapeutics 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06598969
What this trial is testing

TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic SyndromesMyeloid Leukemia, Acute
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 58
Not applicableAvailableNCT01881334
What this trial is testing

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Who this might be right for
Hematologic MalignanciesInborn Errors of Metabolism DisordersImmune Deficiencies
Joanne Kurtzberg, MD
Not applicableStudy completedNCT06790680
What this trial is testing

GITMO AML/MDS-Relapse Registry Study

Who this might be right for
Acute Myeloid LeukaemiaMyelodysplastic Syndrome
Gruppo Italiano Trapianto di Midollo Osseo 859
Testing effectiveness (Phase 2)Study completedNCT00053196
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+3 more
Alliance for Clinical Trials in Oncology 82
Testing effectiveness (Phase 2)Study completedNCT00049634
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01824693
What this trial is testing

Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia

Who this might be right for
Juvenile Myelomonocytic Leukemia
Children's Oncology Group 30
Early research (Phase 1)Ended earlyNCT02995330
What this trial is testing

Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Testing effectiveness (Phase 2)Looking for participantsNCT05470491
What this trial is testing

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

Who this might be right for
HIVHematologic Malignancies
National Cancer Institute (NCI) 265
Testing effectiveness (Phase 2)Study completedNCT00006350
What this trial is testing

Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore
Next Page